Psoriatic arthritis (PsA ... with both pharmacological and non-pharmacological treatments now available. The EULAR recommendations for pharmacological management in PsA were first written in ...

[2] The group recommended treatment for all aspects of PsA, including peripheral and axial arthritis ... steroid or DMARD use. The European League Against Rheumatism (EULAR) published their ...

Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of ...

EULAR 2024 Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in ...

There are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of Associations for ...

—Multidisciplinary approaches to the diagnosis and management of patients with suspected or diagnosed psoriatic arthritis may lead to better diagnostic precision and more focused treatment.

Eli Lilly’s Taltz has beaten AbbVie’s blockbuster Humira in a psoriatic arthritis study involving ... At the Annual European Congress of Rheumatology (EULAR) in Madrid it has now revealed ...